U.S. flag

An official website of the United States government

NM_024675.3(PALB2):c.3362delG (p.Gly1121Valfs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 18, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000235614.1

Allele description

NM_024675.3(PALB2):c.3362delG (p.Gly1121Valfs)

Gene:
PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
16p12.2
Genomic location:
Preferred name:
NM_024675.3(PALB2):c.3362delG (p.Gly1121Valfs)
HGVS:
  • NC_000016.10:g.23603658delC
  • NG_007406.1:g.42700delG
  • NM_024675.3:c.3362delG
  • NP_078951.2:p.Gly1121Valfs
  • LRG_308t1:c.3362delG
  • LRG_308:g.42700delG
  • LRG_308p1:p.Gly1121Valfs
  • NC_000016.9:g.23614979delC
  • NM_024675.3:c.3362del
  • p.(Gly1121Valfs*3)
  • p.G1121VFS*3
  • r.(?)
Links:
PALB2 database: PALB2_10208; dbSNP: rs515726117
NCBI 1000 Genomes Browser:
rs515726117
Molecular consequence:
  • NM_024675.3:c.3362delG - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Identifiers:
MedGen: CN221809

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000292661GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Jan 18, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000292661.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This deletion of one nucleotide in PALB2 is denoted c.3362delG at the cDNA level and p.Gly1121ValfsX3 (G1121VfsX3) at the protein level. The normal sequence, with the base that is deleted in braces, is GAAG{G}TGAC. The deletion causes a frameshift, which changes a Glycine to a Valine at codon 1121, and creates a premature stop codon at position 3 of the new reading frame. Even though this frameshift occurs in the last exon of the gene, it is significant since the last 66 correct amino acids are lost; furthermore, truncating pathogenic variants downstream of this one have been identified in other breast/pancreatic families (Rahman 2007, Peterlongo 2011). This variant is predicted to cause loss of normal protein function through protein truncation. This variant has been reported in families with a history of breast cancer, with at least one family also having a history of pancreatic cancer (Blanco 2013, Janatova 2013, Antoniou 2014, Castera 2014, Thompson 2015). We consider this variant to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 3, 2016